BioNTech SE Sponsored ADR (BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Truist initiated coverage on BioNTech SE (NASDAQ:BNTX), a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc ...

(Reuters) -BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its ...

In the database, there are reports of individuals contracting mpox at some point after receiving the Pfizer-BioNTech COVID-19 ... vaccines cannot cause mpox, as USA TODAY previously reported.

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on BioNTech SE (BNTX – Research Report) yesterday and set a price ...

Pfizer and its German collaborator BioNTech applied for emergency use authorization ... COVID-19 vaccine could be administered across the USA, though the week of Dec. 14 is more likely.

A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...

Congratulations USA! Congratulations WORLD ... virus wave yet Trump rejects early White House vaccinations The Pfizer/BioNTech vaccine received emergency-use authorisation from the US Food ...

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Updated Dec. 8 at 1:30 p.m. Pfizer enrolled approximately 44,000 people ...